New Results

In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis

Sridharan Brindha, Jagadish Chandrabose Sundaramurthi, Savariar Vincent, Devadasan Velmurugan, John Joel Gnanadoss
doi: https://doi.org/10.1101/228171

Article usage

Article usage: January 2018 to December 2023

AbstractFullPdf
Jan 201846025
Feb 201840043
Mar 201865032
Apr 201827014
May 201838029
Jun 201832029
Jul 201826022
Aug 201839031
Sep 201826019
Oct 201834022
Nov 201834030
Dec 201826020
Jan 201928016
Feb 201912014
Mar 201933021
Apr 201920913
May 2019141622
Jun 2019242817
Jul 2019173120
Aug 2019231614
Oct 2019221910
Nov 2019551911
Dec 2019732419
Jan 2020461714
Feb 2020472119
Mar 202014109
May 2020261811
Jun 2020121117
Jul 202019721
Aug 202026612
Sep 20202349
Oct 20209112
Nov 202025108
Dec 2020696
Jan 20214179
Feb 2021101211
Mar 20218105
Apr 202117914
May 20218314
Jun 202161011
Jul 20215513
Aug 202112910
Sep 202111915
Oct 20215822
Nov 202110719
Dec 2021824
Jan 20227111
Feb 2022406
Mar 20221276
Apr 2022806
May 20225516
Jun 2022319
Jul 20221142
Aug 20224216
Sep 20226311
Oct 2022627
Nov 202218423
Dec 2022412
Jan 2023673
Feb 2023715
Mar 2023414
Apr 20233011
May 202351210
Jun 2023234
Jul 20233011
Aug 20237310
Sep 2023516
Oct 202311513
Nov 20231132
Dec 2023110
Back to top
Posted December 03, 2017.
Download PDF
Email
In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis
Sridharan Brindha, Jagadish Chandrabose Sundaramurthi, Savariar Vincent, Devadasan Velmurugan, John Joel Gnanadoss
bioRxiv 228171; doi: https://doi.org/10.1101/228171
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area